img

Global Rabies Immunoglobulins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rabies Immunoglobulins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rabies Immunoglobulins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rabies Immunoglobulins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Category II Exposure and Category III Exposure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rabies Immunoglobulins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Rabies Immunoglobulins key manufacturers include CSL Behring, Grifols, Sanofi, Kamada, Sichuan Yuanda Shuyang, Shuanglin Bio, Weiguang Bio, Shanghai RAAS and Bharat Serum, etc. CSL Behring, Grifols, Sanofi are top 3 players and held % sales share in total in 2022.
Rabies Immunoglobulins can be divided into ERIG and HRIG, etc. ERIG is the mainstream product in the market, accounting for % sales share globally in 2022.
Rabies Immunoglobulins is widely used in various fields, such as Category II Exposure and Category III Exposure, etc. Category II Exposure provides greatest supports to the Rabies Immunoglobulins industry development. In 2022, global % sales of Rabies Immunoglobulins went into Category II Exposure filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rabies Immunoglobulins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Behring
Grifols
Sanofi
Kamada
Sichuan Yuanda Shuyang
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS BioProducts
Tiantan Biological
Hualan Bio
China-Boya
China Biologic Products
Segment by Type
ERIG
HRIG

Segment by Application


Category II Exposure
Category III Exposure

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Immunoglobulins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rabies Immunoglobulins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rabies Immunoglobulins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Rabies Immunoglobulins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rabies Immunoglobulins introduction, etc. Rabies Immunoglobulins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rabies Immunoglobulins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Rabies Immunoglobulins Market Overview
1.1 Rabies Immunoglobulins Product Overview
1.2 Rabies Immunoglobulins Market Segment by Type
1.2.1 ERIG
1.2.2 HRIG
1.3 Global Rabies Immunoglobulins Market Size by Type
1.3.1 Global Rabies Immunoglobulins Market Size Overview by Type (2024-2034)
1.3.2 Global Rabies Immunoglobulins Historic Market Size Review by Type (2024-2024)
1.3.3 Global Rabies Immunoglobulins Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rabies Immunoglobulins Sales Breakdown by Type (2024-2024)
1.4.2 Europe Rabies Immunoglobulins Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Rabies Immunoglobulins Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Rabies Immunoglobulins Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Rabies Immunoglobulins Sales Breakdown by Type (2024-2024)
2 Global Rabies Immunoglobulins Market Competition by Company
2.1 Global Top Players by Rabies Immunoglobulins Sales (2024-2024)
2.2 Global Top Players by Rabies Immunoglobulins Revenue (2024-2024)
2.3 Global Top Players by Rabies Immunoglobulins Price (2024-2024)
2.4 Global Top Manufacturers Rabies Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rabies Immunoglobulins Market Competitive Situation and Trends
2.5.1 Rabies Immunoglobulins Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rabies Immunoglobulins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Immunoglobulins as of 2022)
2.7 Date of Key Manufacturers Enter into Rabies Immunoglobulins Market
2.8 Key Manufacturers Rabies Immunoglobulins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rabies Immunoglobulins Status and Outlook by Region
3.1 Global Rabies Immunoglobulins Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Rabies Immunoglobulins Historic Market Size by Region
3.2.1 Global Rabies Immunoglobulins Sales in Volume by Region (2024-2024)
3.2.2 Global Rabies Immunoglobulins Sales in Value by Region (2024-2024)
3.2.3 Global Rabies Immunoglobulins Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Rabies Immunoglobulins Forecasted Market Size by Region
3.3.1 Global Rabies Immunoglobulins Sales in Volume by Region (2024-2034)
3.3.2 Global Rabies Immunoglobulins Sales in Value by Region (2024-2034)
3.3.3 Global Rabies Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Rabies Immunoglobulins by Application
4.1 Rabies Immunoglobulins Market Segment by Application
4.1.1 Category II Exposure
4.1.2 Category III Exposure
4.2 Global Rabies Immunoglobulins Market Size by Application
4.2.1 Global Rabies Immunoglobulins Market Size Overview by Application (2024-2034)
4.2.2 Global Rabies Immunoglobulins Historic Market Size Review by Application (2024-2024)
4.2.3 Global Rabies Immunoglobulins Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rabies Immunoglobulins Sales Breakdown by Application (2024-2024)
4.3.2 Europe Rabies Immunoglobulins Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Rabies Immunoglobulins Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Rabies Immunoglobulins Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Rabies Immunoglobulins Sales Breakdown by Application (2024-2024)
5 North America Rabies Immunoglobulins by Country
5.1 North America Rabies Immunoglobulins Historic Market Size by Country
5.1.1 North America Rabies Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Rabies Immunoglobulins Sales in Volume by Country (2024-2024)
5.1.3 North America Rabies Immunoglobulins Sales in Value by Country (2024-2024)
5.2 North America Rabies Immunoglobulins Forecasted Market Size by Country
5.2.1 North America Rabies Immunoglobulins Sales in Volume by Country (2024-2034)
5.2.2 North America Rabies Immunoglobulins Sales in Value by Country (2024-2034)
6 Europe Rabies Immunoglobulins by Country
6.1 Europe Rabies Immunoglobulins Historic Market Size by Country
6.1.1 Europe Rabies Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Rabies Immunoglobulins Sales in Volume by Country (2024-2024)
6.1.3 Europe Rabies Immunoglobulins Sales in Value by Country (2024-2024)
6.2 Europe Rabies Immunoglobulins Forecasted Market Size by Country
6.2.1 Europe Rabies Immunoglobulins Sales in Volume by Country (2024-2034)
6.2.2 Europe Rabies Immunoglobulins Sales in Value by Country (2024-2034)
7 Asia-Pacific Rabies Immunoglobulins by Region
7.1 Asia-Pacific Rabies Immunoglobulins Historic Market Size by Region
7.1.1 Asia-Pacific Rabies Immunoglobulins Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Rabies Immunoglobulins Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Rabies Immunoglobulins Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Rabies Immunoglobulins Forecasted Market Size by Region
7.2.1 Asia-Pacific Rabies Immunoglobulins Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Rabies Immunoglobulins Sales in Value by Region (2024-2034)
8 Latin America Rabies Immunoglobulins by Country
8.1 Latin America Rabies Immunoglobulins Historic Market Size by Country
8.1.1 Latin America Rabies Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Rabies Immunoglobulins Sales in Volume by Country (2024-2024)
8.1.3 Latin America Rabies Immunoglobulins Sales in Value by Country (2024-2024)
8.2 Latin America Rabies Immunoglobulins Forecasted Market Size by Country
8.2.1 Latin America Rabies Immunoglobulins Sales in Volume by Country (2024-2034)
8.2.2 Latin America Rabies Immunoglobulins Sales in Value by Country (2024-2034)
9 Middle East and Africa Rabies Immunoglobulins by Country
9.1 Middle East and Africa Rabies Immunoglobulins Historic Market Size by Country
9.1.1 Middle East and Africa Rabies Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Rabies Immunoglobulins Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Rabies Immunoglobulins Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Rabies Immunoglobulins Forecasted Market Size by Country
9.2.1 Middle East and Africa Rabies Immunoglobulins Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Rabies Immunoglobulins Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.1.4 CSL Behring Rabies Immunoglobulins Products Offered
10.1.5 CSL Behring Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Grifols Rabies Immunoglobulins Products Offered
10.2.5 Grifols Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi Rabies Immunoglobulins Products Offered
10.3.5 Sanofi Recent Development
10.4 Kamada
10.4.1 Kamada Company Information
10.4.2 Kamada Introduction and Business Overview
10.4.3 Kamada Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Kamada Rabies Immunoglobulins Products Offered
10.4.5 Kamada Recent Development
10.5 Sichuan Yuanda Shuyang
10.5.1 Sichuan Yuanda Shuyang Company Information
10.5.2 Sichuan Yuanda Shuyang Introduction and Business Overview
10.5.3 Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sichuan Yuanda Shuyang Rabies Immunoglobulins Products Offered
10.5.5 Sichuan Yuanda Shuyang Recent Development
10.6 Shuanglin Bio
10.6.1 Shuanglin Bio Company Information
10.6.2 Shuanglin Bio Introduction and Business Overview
10.6.3 Shuanglin Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Shuanglin Bio Rabies Immunoglobulins Products Offered
10.6.5 Shuanglin Bio Recent Development
10.7 Weiguang Bio
10.7.1 Weiguang Bio Company Information
10.7.2 Weiguang Bio Introduction and Business Overview
10.7.3 Weiguang Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Weiguang Bio Rabies Immunoglobulins Products Offered
10.7.5 Weiguang Bio Recent Development
10.8 Shanghai RAAS
10.8.1 Shanghai RAAS Company Information
10.8.2 Shanghai RAAS Introduction and Business Overview
10.8.3 Shanghai RAAS Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Shanghai RAAS Rabies Immunoglobulins Products Offered
10.8.5 Shanghai RAAS Recent Development
10.9 Bharat Serum
10.9.1 Bharat Serum Company Information
10.9.2 Bharat Serum Introduction and Business Overview
10.9.3 Bharat Serum Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bharat Serum Rabies Immunoglobulins Products Offered
10.9.5 Bharat Serum Recent Development
10.10 VINS BioProducts
10.10.1 VINS BioProducts Company Information
10.10.2 VINS BioProducts Introduction and Business Overview
10.10.3 VINS BioProducts Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.10.4 VINS BioProducts Rabies Immunoglobulins Products Offered
10.10.5 VINS BioProducts Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Tiantan Biological Rabies Immunoglobulins Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 Hualan Bio
10.12.1 Hualan Bio Company Information
10.12.2 Hualan Bio Introduction and Business Overview
10.12.3 Hualan Bio Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Hualan Bio Rabies Immunoglobulins Products Offered
10.12.5 Hualan Bio Recent Development
10.13 China-Boya
10.13.1 China-Boya Company Information
10.13.2 China-Boya Introduction and Business Overview
10.13.3 China-Boya Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.13.4 China-Boya Rabies Immunoglobulins Products Offered
10.13.5 China-Boya Recent Development
10.14 China Biologic Products
10.14.1 China Biologic Products Company Information
10.14.2 China Biologic Products Introduction and Business Overview
10.14.3 China Biologic Products Rabies Immunoglobulins Sales, Revenue and Gross Margin (2024-2024)
10.14.4 China Biologic Products Rabies Immunoglobulins Products Offered
10.14.5 China Biologic Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rabies Immunoglobulins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rabies Immunoglobulins Industrial Chain Analysis
11.4 Rabies Immunoglobulins Market Dynamics
11.4.1 Rabies Immunoglobulins Industry Trends
11.4.2 Rabies Immunoglobulins Market Drivers
11.4.3 Rabies Immunoglobulins Market Challenges
11.4.4 Rabies Immunoglobulins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rabies Immunoglobulins Distributors
12.3 Rabies Immunoglobulins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ERIG
Table 2. Major Company of HRIG
Table 3. Global Rabies Immunoglobulins Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Rabies Immunoglobulins Sales by Type (2024-2024) & (M Units)
Table 5. Global Rabies Immunoglobulins Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Rabies Immunoglobulins Sales by Type (2024-2024) & (US& Million)
Table 7. Global Rabies Immunoglobulins Market Share in Value by Type (2024-2024)
Table 8. Global Rabies Immunoglobulins Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Rabies Immunoglobulins Sales by Type (2024-2034) & (M Units)
Table 10. Global Rabies Immunoglobulins Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Rabies Immunoglobulins Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Rabies Immunoglobulins Sales Market Share in Value by Type (2024-2034)
Table 13. Global Rabies Immunoglobulins Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Rabies Immunoglobulins Sales by Type (2024-2024) & (M Units)
Table 15. North America Rabies Immunoglobulins Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Rabies Immunoglobulins Sales (M Units) by Type (2024-2024)
Table 17. Europe Rabies Immunoglobulins Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Rabies Immunoglobulins Sales (M Units) by Type (2024-2024)
Table 19. Asia-Pacific Rabies Immunoglobulins Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Rabies Immunoglobulins Sales (M Units) by Type (2024-2024)
Table 21. Latin America Rabies Immunoglobulins Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Rabies Immunoglobulins Sales (M Units) by Type (2024-2024)
Table 23. Middle East and Africa Rabies Immunoglobulins Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Rabies Immunoglobulins Sales by Company (2024-2024) & (M Units)
Table 25. Global Rabies Immunoglobulins Sales Share by Company (2024-2024)
Table 26. Global Rabies Immunoglobulins Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Rabies Immunoglobulins Revenue Share by Company (2024-2024)
Table 28. Global Market Rabies Immunoglobulins Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Rabies Immunoglobulins Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Rabies Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Immunoglobulins as of 2022)
Table 32. Date of Key Manufacturers Enter into Rabies Immunoglobulins Market
Table 33. Key Manufacturers Rabies Immunoglobulins Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Rabies Immunoglobulins Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Rabies Immunoglobulins Sales by Region (2024-2024) & (M Units)
Table 37. Global Rabies Immunoglobulins Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Rabies Immunoglobulins Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Rabies Immunoglobulins Sales Market Share in Value by Region (2024-2024)
Table 40. Global Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Rabies Immunoglobulins Sales by Region (2024-2034) & (M Units)
Table 42. Global Rabies Immunoglobulins Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Rabies Immunoglobulins Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Rabies Immunoglobulins Sales Market Share in Value by Region (2024-2034)
Table 45. Global Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Rabies Immunoglobulins Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Rabies Immunoglobulins Sales by Application (2024-2024) & (M Units)
Table 48. Global Rabies Immunoglobulins Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Rabies Immunoglobulins Sales Market Share in Value by Application (2024-2024)
Table 51. Global Rabies Immunoglobulins Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Rabies Immunoglobulins Sales by Application (2024-2034) & (M Units)
Table 53. Global Rabies Immunoglobulins Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Rabies Immunoglobulins Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Rabies Immunoglobulins Sales Market Share in Value by Application (2024-2034)
Table 56. Global Rabies Immunoglobulins Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Rabies Immunoglobulins Sales by Application (2024-2024) (M Units)
Table 58. North America Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Rabies Immunoglobulins Sales by Application (2024-2024) (M Units)
Table 60. Europe Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Rabies Immunoglobulins Sales by Application (2024-2024) (M Units)
Table 62. Asia-Pacific Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Rabies Immunoglobulins Sales by Application (2024-2024) (M Units)
Table 64. Latin America Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Rabies Immunoglobulins Sales by Application (2024-2024) (M Units)
Table 66. Middle East and Africa Rabies Immunoglobulins Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Rabies Immunoglobulins Sales by Country (2024-2024) & (M Units)
Table 68. North America Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Rabies Immunoglobulins Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2024)
Table 71. North America Rabies Immunoglobulins Sales by Country (2024-2034) & (M Units)
Table 72. North America Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Rabies Immunoglobulins Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Rabies Immunoglobulins Sales by Country (2024-2024) & (M Units)
Table 76. Europe Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Rabies Immunoglobulins Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Rabies Immunoglobulins Sales by Country (2024-2034) & (M Units)
Table 80. Europe Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Rabies Immunoglobulins Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Rabies Immunoglobulins Sales by Region (2024-2024) & (M Units)
Table 84. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Rabies Immunoglobulins Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Rabies Immunoglobulins Sales by Region (2024-2034) & (M Units)
Table 88. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Rabies Immunoglobulins Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Rabies Immunoglobulins Sales by Country (2024-2024) & (M Units)
Table 92. Latin America Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Rabies Immunoglobulins Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Rabies Immunoglobulins Sales by Country (2024-2034) & (M Units)
Table 96. Latin America Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Rabies Immunoglobulins Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Rabies Immunoglobulins Sales by Country (2024-2024) & (M Units)
Table 100. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Rabies Immunoglobulins Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Rabies Immunoglobulins Sales by Country (2024-2034) & (M Units)
Table 104. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Rabies Immunoglobulins Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Value by Country (2024-2034)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Introduction and Business Overview
Table 109. CSL Behring Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. CSL Behring Rabies Immunoglobulins Product
Table 111. CSL Behring Recent Development
Table 112. Grifols Company Information
Table 113. Grifols Introduction and Business Overview
Table 114. Grifols Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Grifols Rabies Immunoglobulins Product
Table 116. Grifols Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Sanofi Rabies Immunoglobulins Product
Table 121. Sanofi Recent Development
Table 122. Kamada Company Information
Table 123. Kamada Introduction and Business Overview
Table 124. Kamada Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Kamada Rabies Immunoglobulins Product
Table 126. Kamada Recent Development
Table 127. Sichuan Yuanda Shuyang Company Information
Table 128. Sichuan Yuanda Shuyang Introduction and Business Overview
Table 129. Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Sichuan Yuanda Shuyang Rabies Immunoglobulins Product
Table 131. Sichuan Yuanda Shuyang Recent Development
Table 132. Shuanglin Bio Company Information
Table 133. Shuanglin Bio Introduction and Business Overview
Table 134. Shuanglin Bio Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Shuanglin Bio Rabies Immunoglobulins Product
Table 136. Shuanglin Bio Recent Development
Table 137. Weiguang Bio Company Information
Table 138. Weiguang Bio Introduction and Business Overview
Table 139. Weiguang Bio Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Weiguang Bio Rabies Immunoglobulins Product
Table 141. Weiguang Bio Recent Development
Table 142. Shanghai RAAS Company Information
Table 143. Shanghai RAAS Introduction and Business Overview
Table 144. Shanghai RAAS Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Shanghai RAAS Rabies Immunoglobulins Product
Table 146. Shanghai RAAS Recent Development
Table 147. Bharat Serum Company Information
Table 148. Bharat Serum Introduction and Business Overview
Table 149. Bharat Serum Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Bharat Serum Rabies Immunoglobulins Product
Table 151. Bharat Serum Recent Development
Table 152. VINS BioProducts Company Information
Table 153. VINS BioProducts Introduction and Business Overview
Table 154. VINS BioProducts Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. VINS BioProducts Rabies Immunoglobulins Product
Table 156. VINS BioProducts Recent Development
Table 157. Tiantan Biological Company Information
Table 158. Tiantan Biological Introduction and Business Overview
Table 159. Tiantan Biological Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Tiantan Biological Rabies Immunoglobulins Product
Table 161. Tiantan Biological Recent Development
Table 162. Hualan Bio Company Information
Table 163. Hualan Bio Introduction and Business Overview
Table 164. Hualan Bio Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Hualan Bio Rabies Immunoglobulins Product
Table 166. Hualan Bio Recent Development
Table 167. China-Boya Company Information
Table 168. China-Boya Introduction and Business Overview
Table 169. China-Boya Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. China-Boya Rabies Immunoglobulins Product
Table 171. China-Boya Recent Development
Table 172. China Biologic Products Company Information
Table 173. China Biologic Products Introduction and Business Overview
Table 174. China Biologic Products Rabies Immunoglobulins Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. China Biologic Products Rabies Immunoglobulins Product
Table 176. China Biologic Products Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Rabies Immunoglobulins Market Trends
Table 180. Rabies Immunoglobulins Market Drivers
Table 181. Rabies Immunoglobulins Market Challenges
Table 182. Rabies Immunoglobulins Market Restraints
Table 183. Rabies Immunoglobulins Distributors List
Table 184. Rabies Immunoglobulins Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Immunoglobulins Product Picture
Figure 2. Global Rabies Immunoglobulins Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rabies Immunoglobulins Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Rabies Immunoglobulins Sales Status and Outlook (2024-2034) & (M Units)
Figure 5. Product Picture of ERIG
Figure 6. Global ERIG Sales YoY Growth (2024-2034) & (M Units)
Figure 7. Product Picture of HRIG
Figure 8. Global HRIG Sales YoY Growth (2024-2034) & (M Units)
Figure 9. Global Rabies Immunoglobulins Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Rabies Immunoglobulins Sales Market Share by Type in 2022 & 2034
Figure 11. North America Rabies Immunoglobulins Sales Market Share in Volume by Type in 2022
Figure 12. North America Rabies Immunoglobulins Sales Market Share in Value by Type in 2022
Figure 13. Europe Rabies Immunoglobulins Sales Market Share in Volume by Type in 2022
Figure 14. Europe Rabies Immunoglobulins Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Value by Type in 2022
Figure 17. Latin America Rabies Immunoglobulins Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Rabies Immunoglobulins Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Immunoglobulins Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Immunoglobulins Revenue in 2022
Figure 23. Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Category II Exposure
Figure 25. Global Category II Exposure Sales YoY Growth (2024-2034) & (M Units)
Figure 26. Product Picture of Category III Exposure
Figure 27. Global Category III Exposure Sales YoY Growth (2024-2034) & (M Units)
Figure 28. Global Rabies Immunoglobulins Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Rabies Immunoglobulins Sales Market Share by Application in 2022 & 2034
Figure 30. North America Rabies Immunoglobulins Sales Market Share in Volume by Application in 2022
Figure 31. North America Rabies Immunoglobulins Sales Market Share in Value by Application in 2022
Figure 32. Europe Rabies Immunoglobulins Sales Market Share in Volume by Application in 2022
Figure 33. Europe Rabies Immunoglobulins Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Rabies Immunoglobulins Sales Market Share in Value by Application in 2022
Figure 36. Latin America Rabies Immunoglobulins Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Rabies Immunoglobulins Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Rabies Immunoglobulins Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Rabies Immunoglobulins Manufacturing Cost Structure
Figure 41. Rabies Immunoglobulins Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed